Cardiac complications after elective major vascular surgery

Acta Anaesthesiologica Scandinavica

Volumn 47, Issue 6, 2003, Pages 643-654

  Kertai, M D ^a   Klein, J ^a   Van Urk, H ^a   Bax, J J ^a   Poldermans, Don ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

B advenergic antagonists; Cardiac complications; Non invasive tests; Risk assessment; Vascular surgery

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANESTHETIC AGENT; ANTITHROMBOCYTIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CLONIDINE; DILTIAZEM; DIPYRIDAMOLE; DOBUTAMINE; GLYCERYL TRINITRATE; MIVAZEROL;

ABDOMINAL SURGERY; AMBULATORY MONITORING; ANESTHESIA INDUCTION; AORTA SURGERY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DRUG DOSE REGIMEN; ELECTIVE SURGERY; ELECTROCARDIOGRAPHY MONITORING; EXERCISE ELECTROCARDIOGRAPHY; FATALITY; FOLLOW UP; HEART ARRHYTHMIA; HEART DEATH; HEART DISEASE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEART PROTECTION; HIGH RISK POPULATION; HUMAN; HYPOTENSION; INTERMETHOD COMPARISON; KIDNEY FAILURE; NON INVASIVE MEASUREMENT; OBSERVER VARIATION; OUTCOMES RESEARCH; PATHOPHYSIOLOGY; PATIENT MONITORING; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; PREDICTION; PREOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RADIOISOTOPE VENTRICULOGRAPHY; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK MANAGEMENT; SAFETY; SCINTIGRAPHY; STRESS ECHOCARDIOGRAPHY; STROKE; SURGICAL MORTALITY; SURGICAL RISK; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT INDICATION; TREATMENT OUTCOME; VASCULAR SURGERY;

ANESTHESIA; ECHOCARDIOGRAPHY; HEART DISEASES; HUMANS; MYOCARDIAL REVASCULARIZATION; POSTOPERATIVE COMPLICATIONS; RISK ASSESSMENT; VASCULAR SURGICAL PROCEDURES;

EID: 0037869085     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-6576.2003.00149.x     Document Type: Review

References (78)

1. Konings-Dalstra JAA, Reitsma JB. Hart- en vaatziekten in Nederland 1999, cijfers over ziekte ensterfte. Den Haag: Nederlandse Hartstichting, 1999.
2. The UK Small Aneurysm Trial Participants. Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small aortic aneurysms. Lancet 1998: 352: 1649-55.
3. Hertzer NR, Beven EG, Young JR, O'Hare PJ, Ruschhaupt WF, III, Graor RA et al. Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management. Ann Surg 1984: 199: 223-33.
4. Krupski WC, Layug EL, Reilly LM, Rapp JH, Mangano DT. Comparison of cardiac morbidity rates between aortic and infrainguinal operations: two-year follow-up. Study of Perioperative Ischemia Research Group. J Vasc Surg 1993: 18: 609-15.
5. L'Italien GJ, Cambria RP, Cutler BS, Leppo JA, Paul SD, Brewster DC et al. Comparative early and late cardiac morbidity among patients requiring different vascular surgery procedures. J Vasc Surg 1995: 21: 935-44.
6. Krupski WC. Update on perioperative evaluation and management of cardiac disease in vascular surgery patients. J Vasc Surg 2002: 36: 1292-308.
7. Mangano DT. Perioperative cardiac morbidity. Anaesthesiology 1990: 72: 153-84.
8. Poldermans D, Boersma E, Bax JJ, Thomson IR, van de Ven L, Blankensteijn JD et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med 1999: 341: 1789-94.
9. Dawood MM, Gutpa DK, Southern J, Walia A, Atkinson JB, Eagle KA. Pathology of fatal perioperative myocardial infarction: implications regarding pathophysiology and prevention. Int J Cardiol 1996: 57: 37-44.
10. Poldermans D, Boersma E, Bax JJ, Kliffen M, van Urk H, van de Ven L et al. Correlation of location of acute myocardial infarct after noncardiac vascular surgery with preoperative dobutamine echocardiographic findings. Am J Cardiol 2001: 88: 1413-4.
11. Cohen MC, Aretz TH. Histological analysis of coronary artery lesions in fatal postoperative myocardial infarction. Cardiovasc Pathol 1999: 8: 133-9.
12. Landesberg G, Luria MH, Cotev S. Importance of long-duration postoperative ST-segment depression in cardiac morbidity after vascular surgery [see comments]. Lancet 1993: 341: 715-9.
13. Fleisher LA. Risk indices: what is their value to the clinician and patient? Anesthesiology 2001: 94: 191-3.
14. Rapp HJ, Rabethge S, Luiz T, Haux P. Perioperative ST-segment depression and troponin T release. Identification of patients with highest risk for myocardial damage. Acta Anaesthesiol Scand 1999: 43: 124-9.
15. Hynynen M. Perioperative myocardial ischemia in patients undergoing noncardiac surgery: does prolonged ischemia result in myocardial necrosis? Acta Anaesthesiol Scand 1999: 43: 121-3.
16. Goldman L. Assessment of perioperative cardiac risk. N Engl J Med 1994: 330: 707-9.
17. Detsky AS, Howard BA, Forbath N, Scott JG, Hilliard JR. Cardiac assessment for patients undergoing noncardiac surgery. A multifactorial clinical risk index. Arch Intern Med 1986: 146: 2131-4.
18. Eagle KA, Coley CM, Newell JB, Brewster DC, Darling RC, Strauss HW et al. Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery. Ann Intern Med 1989: 110: 859-66.
19. Gilbert K, Larocque BJ, Patrick LT. Prospective evaluation of cardiac risk indices for patients undergoing noncardiac surgery. Ann Intern Med 2000: 133: 356-9.
20. Lee T, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999: 100: 1043-9.
21. Eagle KA, Berger PB, Calkins H, Chaitman BR, Ewy GA, Fleischmann KE et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery - executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation 2002: 105: 1257-7.
22. Bartels C, Bechtel JF, Hossmann V, Horsch S. Cardiac risk stratification for high-risk vascular surgery. Circulation 1997: 95: 2473-5.
23. Morgan PB, Panomitros GE, Nelson AC, Smith DF, Solanki DR, Zornow MH. Low utility of dobutamine stress echocardiograms in the preoperative evaluation of patients scheduled for noncardiac surgery. Anesth Analg 2002: 95: 512-6.
24. Poldermans D, Arnese M, Fioretti PM, Salustri A, Boersma E, Thomson IR et al. Improved cardiac risk stratification in major vascular surgery with dobutamine-atropine stress echocardiography. J Am Coll Cardiol 1995: 26: 648-53.
25. Boersma E, Poldermans D, Bax JJ, Steyerberg EW, Thomson IR, Banga JD et al. Predictors of cardiac events after major vascular surgery Role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy. JAMA 2001: 285: 1865-73.
26. Kertai MD, Boersma E, Bax JJ, Heijenbroek-Kal MH, Hunink M, Steyerberg EW et al. A meta-analysis comparing the prognostic accuracy of six diagnostic tests for prediction perioperative cardiac risk in patients undergoing major vascular surgery (in press).
27. Poldermans D, Fioretti PM, Forster T, Thomson IR, Boersma E, el-Said EM et al. Dobutamine stress echocardiography for the assessment of perioperative cardiac risk in patients undergoing major non-cardiac vascular surgery. Circulation 1993: 87: 1506-12.
28. Caidahl K, Kazzam E, Lodberg J, Neumann AG, Nordanstig J, Rantapaa DS et al. New concept in echocardiography: harmonic imaging of tissue without the use of contrast. Lancet 1998: 352: 1264-70.
29. Poldermans D, Fioretti PM, Boersma E, Forster T, van Urk H, Cornel JH et al. Safety of dobutamine-atropine stress echocardiography in patients with suspected coronary artery disease. Am J Cardiol 1994: 73: 456-9.
30. Picano E, Mathias W, Pingitori A, Bigi R, Previtali M. Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, multicentre study. Lancet 1994: 344: 1190-2.
31. Poldermans D, Rambaldi R, Bax JJ, Cornel JH, Thomson IR, Valkema R et al. Safety and utility of atropine addition during dobutamine stress echocardiography for the assessment of viable myocardium in patients with severe left ventricular dysfunction. Eur Heart J 1998: 19: 1712-8.
32. Pellikka P, Roger VL, Oh JK, Seward JB, Tajik AJ. Safety of performing dobutamine stress echocardiography in patients with abdominal aortic aneurysm < 4 cm in diameter. Am J Cardiol 1996: 77: 413-6.
33. Brown KA. Prognostic value of thallium-201 myocardial perfusion imaging: a diagnostic tool comes of age. Circulation 1991: 83: 363-81.
34. Rochmis P, Blackburn H. Exercise tests: a survey of procedures, safety and litigation experience in approximately 170000 tests. JAMA 1971: 217: 1061-6.
35. Vincent M, Marwick T, D'Hondt AM. Prediction of perioperative events at vascular surgery: S selection of thallium scintigraphy or echocardiography with dipyridamole stress. Circulation 1992: 86 (Suppl. I): 3142.
36. Shaw LJ, Eagle KA, Gersh BJ, Miller DD. Meta-analysis of intravenous dipyidamole-thallium-201 imaging (1985-94) and dobutamine echocardiography 1991-94 for risk stratification before vascular surgery. J Am Coll Cardiol 1996: 27: 787-9.
37. Mantha S, Roizen MF, Barnard J, Thisted RA, Ellis JE, Foss J. Relative effectiveness of four preoperative tests for predicting adverse cardiac outcomes after vascular surgery: a meta-analysis. Anesth Analg 1994: 79: 422-33.
38. Mangano D, Layug EL, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med 1996: 335: 1713-20.
39. Auerbach AD, Goldman L. Beta-Blockers and reduction of cardiac events in noncardiac surgery: scientific review. JAMA: 287: 1435-44.
40. Ellis JE, Drijvers G, Pedlow S, Laff SP, Sorrentino MJ, Foss JF et al. Premedication with oral and transdermal clonidine provides safe and efficacious postoperative sympatholysis. Anesth Analg 1994: 79: 1133-40.
41. Stuhmeier KD, Mainzer B, Cierpka J, Sandman W, Tarnow J. Small, oral dose of clonidine reduces the incidence of intra-operative myocardial ischemia in patients having vascular surgery. Anesthesiology 1996: 85: 706-12.
42. Oliver MF, Goldman L, Julian DG, Holme I. Effect of mivazerol on perioperative cardiac complications during noncardiac surgery in patients with coronary heart disease: the European Mivazerol Trial (EMIT). Anesthesiology 1999: 91: 951-61.
43. Coriat P, Daloz M, Bousseau D, Fuscuardi J, Echter E, Viars P. Prevention of intraoperative myocardial ischemia during noncardiac surgery with intravenous nitroglycerin. Anesthesiology 1984: 61: 193-6.
44. Godet G, Coriat P, Baron JF, Bertrand M, Diquet B, Sebag C et al. Prevention of intraoperative myocardial ischemia during noncardiac surgery with intravenous diltiazem: a randomised trial versus placebo. Anesthesiology 1987: 66: 241-5.
45. Gottlieb A, Banoub M, Sprung J, Levy PJ, Beven M, Mascha EJ. Perioperative cardiovascular morbidity in patients with coronary artery disease undergoing vascular surgery after percutaneous transluminal coronary angioplasty. J Cardiothorac Vasc Anesth 1998: 12: 501-6.
46. Allen JR, Helling TS, Hartzler GO. Operative procedures not involving the heart after percutaneous transluminal coronary angioplasty. Surg Gynecol Obstet 1991: 173: 285-8.
47. Elmore JR, Hallett JW Jr, Gibbons RJ, Naessens JM, Bower TC, Cherry KJ et al. Myocardial revasoalarization before abdominal aortic aneurysmorrhaphy: effect of coronary angioplasty. Mayo Clin Proc 1993: 68: 637-41.
48. Posner KL, van Norman GA, Chan V. Adverse cardiac outcomes after noncardiac surgery in patients with prior percutaneous transluminal coronary angioplasty. Anesth Analg 1999: 89: 553-60.
49. Kaluza GL, Joseph J, Lee JR, Raizner ME, Raizner AE. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 2000: 35: 1288-94.
50. Eagle KA, Rihal CS, Mickel MC, Holmes DR, Foster ED, Gersh BJ. Cardiac risk of noncardiac surgery: influence of coronary disease and type of surgery in 3368 operations. Circulation 1997: 96: 1882-7.
51. Fleisher LA, Eagle KA, Shaffer T, Anderson GF. Perioperative- and long-term mortality rates after major vascular surgery: the relationship to preoperative testing in the Medicare population. Anesth Analg 1999: 89: 849-55.
52. Hassan SA, Hlatky MA, Boothroyd DB, Winston C, Mark DB, Brooks MM et al. Outcomes of noncardiac surgery after coronary bypass surgery or coronary angioplasty in the Bypass Angioplasty Revascularization Investigation (BARI). Am J Med 2001: 110: 260-6.
53. Pasternack PF, Grossi EA, Baumann FG, Riles TS, Lamparello PJ, Giangola J et al. The value of silent myocardial ischemia monitoring in the prediction of perioperative myocardial infarction in patients undergoing peripheral vascular surgery. J Vasc Surg 1989: 10: 617-25.
54. Eisenberg MJ, London MJ, Leung JM, Browner JS, Hollenberg M, Tubau JF et al. Monitoring for myocardial ischemia during non-cardiac surgery. A technology assessment of transesophageal echocardiography and 12-lead electrocardiography. The Study of Perioperative Ischemia Research Group [see comments]. JAMA 1992: 268: 210-6.
55. Isaacson IJ, Lowdon JD, Berry AJ, Smith RB, III, Knos GB, Weitz FI et al. The value of pulmonary artery and central venous monitoring in patients undergoing abdominal aortic reconstructive surgery: a comparative study of two selected, randomised groups. J Vasc Surg 1990: 12: 754-60.
56. Valentine RJ, Duke ML, Inman NH, Kakish HB, Bengston TD, Glagett GP et al. Effectiveness of pulmonary artery catheters in aortic surgery: a randomised trial. J Vasc Surg 1998: 27: 203-11.
57. Wilson J, Woods I, Fawcett J. Reducing the risk of major elective surgery: randomised controlled trial of preoperative optimisation of oxygen delivery. BMJ 1999: 318: 1099-103.
58. Sandham JD, Hull RD, Brant RF. A randomised, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. N Eng J Med 2003: 348: 5-14.
59. Pronovost PJ, Jenckes MW, Dforman T, Garret E, Breslow MJ, Rosenfeld BA et al. Organizational characteristics of intensive care units related to outcomes of abdominal aortic surgery. JAMA 1999: 281: 1310-7.
60. Dimick JB, Stanley JC, Axelrod DA, Kazmers A, Henke PK, Jacobs LA et al. Impact of hospital volume,M gender and age. Ann SurgE 2002E,M: 235:M,M 579-585.M.
61. Garnett RL, MacIntyre A, Lindsay P, Barber GG, Cole CW, Hajjar G et al. Perioperative ischaemia in aortic surgery:S combined epidural/general anaesthesia and epidural analgesia vs general anaesthesia and i.v. analgesia. Can J Anaesth 1996: 43: 769-77.
62. Baron JF, Bertrand M, Barre E, Godet G, Mundler O, Coriat P et al. Combined epidural and general anesthesia versus general anesthesia for abdominal aortic surgery. Anesthesiology 1991: 75: 611-8.
63. Norris EJ, Beattie C, Perler BA, Martinez EA, Meinert CL, Anderson GF et al. Double-masked randomised trial comparing alternate combinations of intraoperative anesthesia and postoperative analgesia in abdominal aortic surgery. Anesthesiology 2001: 95: 1054-67.
64. Bois S, Couture P, Boudreault DM, Lacombe P, Fugere F, Girard D et al. Epidural analgesia and intravenous patient-controlled analgesia result in similar rates of postoperative myocardial ischemia after aortic surgery. Anesth Analg 1997: 85: 1233-9.
65. Boylan JF, Katz J, Kavanagh BP, Klinck JR, Cheng DC, DeMajo EC et al. Epidural bupivacaine-morphine analgesia versus patient-controlled analgesia following abdominal aortic surgery: analgesic, respiratory, and myocardial effects. Anesthesiology 1998: 89: 585-93.
66. Rodgers A, Walker N, Schug S. Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials. BMJ 2000: 321: 1493-7.
67. Rigg JR, Jamrozik K, Myles PS. Design of the multicenter Australian study of epidural anesthesia and analgesia in major surgery: the MASTER trial. Controlled Clin Trials 2000: 21: 244-56.
68. Tarkkila P, Kaukinen S. Complications during spinal anesthesia: a prospective study. Reg Anesth 1991: 16: 101-6.
69. Tanaka K, Watanabe R, Harada T, Dan K. Extensive application of epidural anesthesia and analgesia in a University hospital: incidence of complications related to technique. Reg Anesth 1993: 18: 34-8.
70. Horlocker T, McGregor D, Matsushige D, Schroeder D, Besse J. A retrospective review of 4767 consecutive spinal anesthetics: central nervous system complications. Anesth Analg 1997: 84: 578-84.
71. Frank SM, Fleisher LA, Breslow MJ, Higgins MS, Olson KF, Kelly S et al. Perioperative maintenance of normothermia reduces the incidence of morbid cardiac events. A randomised clinical trial. JAMA 1997: 277: 1127-34.
72. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined-A consensus document of the joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000: 36: 959-69.
73. Hamm CW, Ravkilde J, Gerhardt WM, Jorgensen P, Peheim E, Ljungdahl L et al. The prognostic value of serum troponin T in unstable angina. N Eng J Med 1992: 327: 146-50.
74. Lee TH, Thomas EJ, Ludwig LE. Troponin T as a marker for myocardial ischemia in patients undergoing major noncardiac surgery. Am J Cardiol 1996: 77: 1031-6.
75. Lopez-Jimenez F, Goldman L, Sacks DB. Prognostic value of cardiac troponin T after noncardiac surgery: 6-month follow-up data. J Am Coll Cardiol 1997: 21: 1241-5.
76. Kim LJ, Martinez EA, Faraday N. Cardiac troponin I predicts short-term mortality in vascular surgery patients. Circulation 2002: 106: 2366-71.
77. Buda AJ. The role of echocardiography in the evaluation of mechanical complications of acute myocardial infarction. Circulation 1991: 84 (Suppl. I): I-109-21.
78. Maunoury C, Chen CC, Chua KB, Thompson CJ. Quantification of left ventricular function with thallium-201 and technetium-99m-sestamibi myocardial gated SPECT.S J Nucl Med 1997: 38: 958-61.